Stan Collender, a cancer patient, shares an interesting New York Times op ed piece on why so few cancer patients participate in clinical trials. Stan is a diagnosed with Merkel cell carcinoma (a rare skin cancer) and is enrolled in a clinical trial with, in his...
A new study released by the international journal Sociology of Health and Illness shows that cancer trials are too long, filled with jargon, and can be intimidating. The study consisted of 13 cancer trials and 26 patients. The authors of the study found that the...
